US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Neuren Pharmaceuticals Ltd (PK) (NURPF) 銘柄情報

Neuren Pharmaceuticals Ltd (PK) (NURPF)

13.46

0.00

( 0.00% )

更新日時： 19:31:58

Neuren Pharmaceuticals Ltd (PK) (NURPF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

13.46

( - )

買値

10.11

売値

13.12

出来高

-

平均取引量 (3 か月)

US$ 435,610

財務取引量

-

0.00 日の範囲 0.00

7.70 52 週間の範囲 14.7965

時価総額

企業価値

1.768B

前日終値

13.46

始値

-

時刻

最終取引時間

-

VWAP

-

歳入

64.65M

純利益

30.44M

発行済株式数

126,323,976

浮動株比率 (%)

86.61%

機関投資家保有比率 (%)

22.37%

配当利回り

PER

70.22

株価売上高倍率 (PSR)

31.93

1 株当たり利益 (EPS)

0.23

ベータ

1.62

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical tr... Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase 2 clinical trial for the treatment of Phelan-McDermid; and in Phase 2 clinical trial for the treatment of Angelman and Pitt Hopkins. In addition, it develops NNZ-2591, which is in preclinical trial stage for the treatment of Prader-Willi syndrome, Hypoxic Ischemic Encephalopathy, and SYNGAP1. The company was incorporated in 2001 and is based in Hawthorn East, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.neurenpharma.com

本社

Hawthorn East, Australia

設立

2026

Neuren Pharmaceuticals Ltd (PK) is listed in the Healthcare sector of the その他OTC with ticker NURPF. The last closing price for Neuren Pharmaceuticals (PK) was US$13.46. Over the last year, Neuren Pharmaceuticals (PK) shares have traded in a share price range of US$ 7.70 to US$ 14.7965.

Neuren Pharmaceuticals (PK) currently has 126,323,976 shares in issue. The market capitalisation of Neuren Pharmaceuticals (PK) is US$1.70 billion. Neuren Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of 70.22.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	4.98	58.7264150943	8.48	13.46	8.48	439	9.98159453	CS
12	4.635	52.5212464589	8.825	13.46	8.48	313	9.65008177	CS
26	0.5538	4.2909609335	12.9062	13.46	7.7	581	10.2187047	CS
52	5.3	64.9509803922	8.16	14.7965	7.7	853	11.80392727	CS
156	4.21	45.5135135135	9.25	17.205	6.17	2636	10.6029261	CS
260	12.2	968.253968254	1.26	17.205	1.26	4481	6.11375169	CS

NURPF - Frequently Asked Questions (FAQ)

What is the current Neuren Pharmaceuticals Ltd (PK) share price?

The current share price of Neuren Pharmaceuticals Ltd (PK) is US$ 13.46

How many Neuren Pharmaceuticals Ltd (PK) shares are in issue?

Neuren Pharmaceuticals Ltd (PK) has 126,323,976 shares in issue

What is the market cap of Neuren Pharmaceuticals Ltd (PK)?

The market capitalisation of Neuren Pharmaceuticals Ltd (PK) is USD 1.7B

What is the 1 year trading range for Neuren Pharmaceuticals Ltd (PK) share price?

Neuren Pharmaceuticals Ltd (PK) has traded in the range of US$ 7.70 to US$ 14.7965 during the past year

What is the PE ratio of Neuren Pharmaceuticals Ltd (PK)?

The price to earnings ratio of Neuren Pharmaceuticals Ltd (PK) is 70.22

What is the cash to sales ratio of Neuren Pharmaceuticals Ltd (PK)?

The cash to sales ratio of Neuren Pharmaceuticals Ltd (PK) is 31.93

What is the registered address of Neuren Pharmaceuticals Ltd (PK)?

The registered address for Neuren Pharmaceuticals Ltd (PK) is 117 Camberwell Road, Hawthorn East, Victoria, 3123

What is the Neuren Pharmaceuticals Ltd (PK) website address?

The website address for Neuren Pharmaceuticals Ltd (PK) is www.neurenpharma.com

Which industry sector does Neuren Pharmaceuticals Ltd (PK) operate in?

Neuren Pharmaceuticals Ltd (PK) operates in the Biotechnology & Life Sciences sector

DrivenByPain

DrivenByPain 2分前

LMMFAO! Liar Basher !

Boing x 2

Boing x 2 2分前

yahoo finance flashing another yellow buy signal/

Stock consultant says next targets are 4.43 and then 4.60.

Boing X 2

jondoeuk

jondoeuk 3分前

Update https://www.fiercebiotech.com/biotech/fates-shelf-car-t-cell-therapy-shows-early-promise-treatment-resistant-autoimmune-disease+

Slides https://www.fatetherapeutics.com/wp-content/uploads/2026/07/ISSCR-_SSC_July-8-2026-Final_clean.pdf

along4zride

along4zride 3分前

THATS A BOLD FACE LIE
Risky pink sheet stock in conservatorship with all profits swept for 18 years. (FNMA)No options no voting rights and at risk of being cancelled all together. Buyer Beware

surfkast

surfkast 3分前

Thanks! I thought so.

gitreal

gitreal 3分前

Why have Torres and the other board members NEVER met personally with investors? Or been interviewed by a legit news organization?

Why are PRs not signed by a Qualified Professional?

Why are the financials not audited? Or the supposed gold stockpile?

Wh

shoondale

shoondale 3分前

🤡 Shareholders are trapped after the massive reverse split under the lies that it would uplist.
Too bad. His company is trading @ .2601!🤣
MWWC is at .0002! 🤣_
So what is the market cap at that scam? Is it over a 1000 times $MWWC like the share price? Try

c3po_3

1 of 5 Overlooked Companies: Lightwave Logic (LWLG): The Bandwidth Choke Point Nobody Priced Inhttps://247wallst.com/investing/2026/07/01/amd-is-up-150-this-year-but-here-are-5-overlooked-stocks-betting-on-what-comes-next/

nowwhat2

nowwhat2 4分前

For the word of T.A. is alive and exerts power and is sharper than any two-edged sword and pierces even to the dividing of soul and spirit, and of joints and [their] marrow, and is able to discern thoughts and intentions of [the] market. And there is not a creation that is not manifest to its' si

thistraderknowsall

thistraderknowsall 5分前

$BTC.X BTC.X Nice rebound!!! Now taking Crypto sister SKL surges to $23 great AI developments! like RAVE did in April.. #1 next runner-up! Congrats!

okwife

CNBX fidelity does not allow opening trades on this stock.

Investorpedia

Investorpedia 6分前

https://x.com/javilealoficial/status/2075281762603741552?s=46

Hoping for something juicy, short term. Good as a time as any to get their game on. New website recently. All good to pave the road ahead, IMO.

WinstonCup

WinstonCup 6分前

I would agree! That is for stocks that have potential! Which is NOT the case for WDLF. Most would agree.

makinezmoney

makinezmoney 6分前

$MX: THe SemiConductor Play not many talk about........................

And still it does over $180Milly in annual sales.

Nice move today to $4.20 as it was sitting at $3.50 just yesterday.

One to watch

https://www.magnachip.com/

brianslate

brianslate 8分前

Market makers are never gonna let this go, they continue to suppress the price and take advantage of traders that don't know you cant sell this without a limit price and their shares get stolen at .000001 after placing market sell orders. GLTA

arachnodude

arachnodude 8分前

Gotta put it in perspective, most of the KBLB complainers are the ones who expected "get-rich-quick" returns. They soured soon after and have hung around to complain ever since. Blaming everyone but their selves for the on-demand wishes.

semi_infinite

semi_infinite 9分前

I have no idea, thought welcomed.

Mr Smith 34

Mr Smith 34 9分前

The court has given the green light for Wick to sell the property. Oddly enough, NO WHERE in the documents does it mention "John Park - Owner / Acquirer" It's just one more lie that he hasn't had to account for (yet).

https://i.ibb.co/ynPpxdgR/Civil-Case-Jacket-20.png

nowwhat2

nowwhat2 10分前

For the word of T.A. is alive and exerts power and is sharper than any two-edged sword and pierces even to the dividing of soul and spirit, and of joints and [their] marrow, and is able to discern thoughts and intentions of [the] market. And there is not a creation that is not manifest to its' si

gshores

gshores 10分前

Nice buying coming in, maybe it finally time.

Brodey79

Brodey79 10分前

I guess they must think they’re farther along in the uplist process than i think they are lol. But that’s cool get the ball rolling. If they’re doing it now they must have something juicy to release with it. If not and they just jumping the gun I guess I’ll keep buying more when I can lol.

manibiotech

manibiotech 10分前

Here is the analysis from GPT 5.5 pro extended thinking:

“””

I’m reading your question as: “Does the MHRA control access to unapproved/unlicensed medicines in the UK for compassionate use?”

Answer: partly, but not usually by approving each individual pati

i_like_bb_stock

i_like_bb_stock 11分前

i_like_bb_stock

i_like_bb_stock 11分前

$NGCG added 0008s

Neuren Pharmaceuticals (PK)

ThermoEnergy (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。